Profiles of Intraday Glucose in Type 2 Diabetes and Their Association with Complications: An Analysis of Continuous Glucose Monitoring Data

被引:16
|
作者
Varghese, Jithin Sam [1 ]
Ho, Joyce C. [2 ]
Anjana, Ranjit Mohan [3 ,4 ]
Pradeepa, Rajendra [3 ,4 ]
Patel, Shivani A. [5 ]
Jebarani, Saravanan [3 ,4 ]
Baskar, Viswanathan [3 ,4 ]
Narayan, K. M. Venkat [5 ]
Mohan, Viswanathan [3 ,4 ]
机构
[1] Emory Univ, Laney Sch Grad Studies, Nutr & Hlth Sci Doctoral Program, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Comp Sci, Atlanta, GA 30322 USA
[3] Dr Mohans Diabet Special Ctr, Dept Diabetol, Chennai 600086, Tamil Nadu, India
[4] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India
[5] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA
关键词
Ambulatory glucose profile; Cluster analysis; Glycemic variability; Time in range; URBAN-RURAL EPIDEMIOLOGY; BLOOD-GLUCOSE; GLYCEMIC CONTROL; CLUSTER-ANALYSIS; ASIAN INDIANS; VARIABILITY; RETINOPATHY; ADULTS; RISK; HYPOGLYCEMIA;
D O I
10.1089/dia.2020.0672
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To identify profiles of type 2 diabetes from continuous glucose monitoring (CGM) data using ambulatory glucose profile (AGP) indicators and examine the association with prevalent complications. Methods: Two weeks of CGM data, collected between 2015 and 2019, from 5901 adult type 2 diabetes patients were retrieved from a clinical database in Chennai, India. Non-negative matrix factorization was used to identify profiles as per AGP indicators. The association of profiles with existing complications was examined using multinomial and logistic regressions adjusted for glycated hemoglobin (HbA1c; %), sex, age at onset, and duration of diabetes. Results: Three profiles of glycemic variability (GV) were identified based on CGM data-Profile 1 ["TIR Profile"] (n = 2271), Profile 2 ["Hypo"] (n = 1471), and Profile 3 ["Hyper"] (n = 2159). Compared with time in range (TIR) profile, those belonging to Hyper had higher mean fasting plasma glucose (202.9 vs. 167.1, mg/dL), 2-h postprandial plasma glucose (302.1 vs. 255.6, mg/dL), and HbA1c (9.7 vs. 8.6; %). Both "Hypo profile" and "Hyper profile" had higher odds of nonproliferative diabetic retinopathy ("Hypo": 1.44, 1.20-1.73; "Hyper": 1.33, 1.11-1.58), macroalbuminuria ("Hypo": 1.58, 1.25-1.98; "Hyper": 1.37, 1.10-1.71), and diabetic kidney disease (DKD; "Hypo": 1.65, 1.18-2.31; "Hyper": 1.88, 1.37-2.58), compared with "TIR profile." Those in "Hypo profile" (vs. "TIR profile") had higher odds of proliferative diabetic retinopathy (PDR; 2.84, 1.65-2.88). Conclusions: We have identified three profiles of GV from CGM data. While both "Hypo profile" and "Hyper profile" had higher odds of prevalent DKD compared with "TIR profile," "Hypo profile" had higher odds of PDR. Our study emphasizes the clinical importance of recognizing and treating hypoglycemia (which is often unrecognized without CGM) in patients with type 2 Diabetes Mellitus.
引用
收藏
页码:555 / 564
页数:10
相关论文
共 50 条
  • [31] Improving glucose control in patients with type 2 diabetes using retrospective continuous glucose monitoring
    Diamond, Katlyn
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2023, 35 (07) : 425 - 433
  • [32] Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections: Does This Mean Continuous Glucose Monitoring for Everyone?
    Arguello, Vanessa
    Freeby, Matthew
    [J]. ANNALS OF INTERNAL MEDICINE, 2017, 167 (06) : 436 - +
  • [33] Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
    Shao, Xiaopeng
    Lu, Jingyi
    Tao, Rui
    Wu, Liang
    Wang, Yaxin
    Lu, Wei
    Li, Hongru
    Zhou, Jian
    Yu, Xia
    [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (06): : 2082 - 2091
  • [34] Compositional Data Analysis of Glucose Profiles of Type 1 Diabetes Patients
    Biagi, Lyvia
    Bertachi, Arthur
    Antoni Martin-Fernandez, Josep
    Vehi, Josep
    [J]. IFAC PAPERSONLINE, 2019, 52 (01): : 1006 - 1011
  • [35] Role of continuous glucose monitoring for type 2 in diabetes management and research
    Vigersky, Robert
    Shrivastav, Maneesh
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (01) : 280 - 287
  • [36] Glucose monitoring in type 2 diabetes
    Cunningham, MA
    [J]. NURSING CLINICS OF NORTH AMERICA, 2001, 36 (02) : 361 - +
  • [37] Continuous glucose monitoring in persons with type 2 diabetes not using insulin
    Cowart, Kevin
    Updike, Wendy H.
    Franks, Rachel
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2021, 18 (11) : 1049 - 1055
  • [38] Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes
    Peek, Monica E.
    Thomas, Celeste C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (22): : 2255 - 2257
  • [39] Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
    Ajjan, Ramzi
    Battelino, Tadej
    Cos, Xavier
    Del Prato, Stefano
    Philips, Jean-Christophe
    Meyer, Laurent
    Seufert, Jochen
    Seidu, Samuel
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2024, 20 (07) : 426 - 440
  • [40] Continuous Glucose Monitoring in Type 2 Diabetes Is Not Ready for Widespread Adoption
    Robertson, Sandy L.
    Shaughnessy, Allen F.
    Slawson, David C.
    [J]. AMERICAN FAMILY PHYSICIAN, 2020, 101 (10) : 646 - 646